BNR - Burning Rock Biotech Ltd - ADR
Previous close
5.5647
0 0%
Share volume: 4,530
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$5.56
0.00
0.00%
Fundamental analysis
14%
Profitability
0%
Dept financing
4%
Liquidity
75%
Performance
15%
Performance
5 Days
-11.75%
1 Month
-22.59%
3 Months
-25.94%
6 Months
-36.51%
1 Year
-61.07%
2 Year
-83.71%
Key data
Stock price
$5.56
DAY RANGE
N/A - N/A
52 WEEK RANGE
$5.18 - $14.00
52 WEEK CHANGE
-$0.61
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
11/21/2024
Company detail
CEO:
Region: US
Website: brbiotech.com
Employees: 55
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Region: US
Website: brbiotech.com
Employees: 55
IPO year: -
Issue type: American Depository Receipt (ADR’s)
Market: XNAS
Industry: Research and Development in Biotechnology (except Nanobiotechnology)
Sector: Professional, Scientific, and Technical Services
Headquartered in China and founded in 2014, Burning Rock, whose mission is to Guard Life via Science, focuses on the application of next generation sequencing (NGS) technology in the field of precision oncology.
Recent news